ACLY and autoimmune polyendocrinopathy: Antiphospholipid syndrome (APS) is an acquired autoimmune, hypercoagulability syndrome characterized by thrombotic and/or obstetric manifestations in association with persistent antiphospholipid autoantibodies (aPL, i.e., anticardiolipin [aCL], anti-β-2glycoprotein I [aB2GPI], lupus anticoagulant [LA]) [1], with an estimated prevalence of 40–50 patients per 100,000 persons [1,2].